While hospitals in the United States are already scrambling to control the impact hospital-based MRSA and its “partner” Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA), they of may well be poised on the brink of the next drug-resistant infection epidemic, with outbreaks of Acinetobacter baumannii already appearing in hospitals here, according to experts speaking at the 2006 annual Interscience Conference on Antimicrobial Agents and Chemotherapy.
The spread of the bacteria has already reached epidemic proportions in Israeli and Latin American hospitals, and poses a serious problem in Europe as well. In fact, “Acinetobacter has been designated as the gram-negative MRSA [methicillin-resistant Staphylococcus aureus],” said Dr. Harald Seifert, a professor at the University of Cologne 's Institute of Medical Microbiology and Hygiene.
We are not only dealing with an increasing incidence of multiresistant Acinetobacter, but we seem to be dealing with an increasing absolute incidence of Acinetobacter,” said Dr. Anthony D. Harris, an epidemiologist for the University of Maryland Medical System , Baltimore .
Acinetobacter baumannii is a nonmotile, gram-negative bacterium that affects mainly immunocompromised patients, particularly patients in the ICU setting or those who have been hospitalized for long periods, Dr. Seifert said at the meeting sponsored by the American Society for Microbiology. Though the organism can cause a wide range of infections, the most common are respiratory tract, bloodstream, urinary tract, skin and soft tissue, and wound infections. http://www.mededsys.com/product_info.php?cPath=1&products_id=69
No comments:
Post a Comment